GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTMY.L Regulatory News (MTMY)

  • There is currently no data for MTMY

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Matomy Media Group Publication of Prospectus

9 Jul 2014 14:24

RNS Number : 8834L
Matomy Media Group Ltd
09 July 2014
 

 

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN, ISRAEL OR AUSTRALIA OR INTO ANY OTHER JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A VIOLATION OR BREACH OF ANY APPLICABLE LAW. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT

 

 

This announcement is an advertisement and not a prospectus and not an offer of securities for sale in any jurisdiction, including in or into the United States, Australia, Canada, Israel or Japan. Neither this announcement nor anything contained herein shall form the basis of, or be relied upon in connection with, any offer or commitment whatsoever in any jurisdiction. Any offer to acquire any securities pursuant to the proposed Offer will be made, and any investor should make his investment decision solely on the basis of the information that is contained in the prospectus (the "Prospectus") published by Matomy Media Group Ltd. ("Matomy" or the "Company") in connection with the admission of its ordinary shares ("Ordinary Shares") to trading on the High Growth Segment of the London Stock Exchange plc's (the "London Stock Exchange") main market ( "Admission"). Copies of the Prospectus will shortly be available from http://www.matomy.com, subject to applicable securities laws, and Matomy's registered office.

 

 

For Immediate Release

 

9 July 2014

 

Matomy Media Group Ltd.

Publication of Prospectus

 

Further to the pricing announcement Matomy Media Group Ltd. ("Matomy") published on 8 July 2014 in connection with its initial public offering ("IPO"), Matomy confirms that the UK Listing Authority has approved its prospectus dated 9 July 2014 (the "Prospectus").

The Prospectus relates to the admission of the Ordinary Shares to trading on the High Growth Segment of the London Stock Exchange's main market.

Further details of Matomy's IPO are set out in the Prospectus, which will shortly be available on Matomy's website (http://www.matomy.com), and at its registered office at 6 Hanechoshet Street, Tel Aviv 6971070, Israel.

A copy of the Prospectus has also been submitted to the National Storage Mechanism, and will shortly be available for inspection at http://www.morningstar.co.uk/uk/NSM.

IMPORTANT NOTICE

This announcement is not for publication or distribution, directly or indirectly, in or into the United States. The distribution of this announcement may be restricted by law in certain jurisdictions and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

This announcement does not contain or constitute an offer of, or the solicitation of an offer to buy, Ordinary Shares to any person in the United States, Australia, Canada, Japan, Israel or in any jurisdiction to whom or in which such offer or solicitation is unlawful.

The Ordinary Shares have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act"), or with any securities regulatory authority or under the laws of any state or jurisdiction of the United States. Accordingly, the Ordinary Shares may not be offered, sold, resold, delivered, distributed or otherwise transferred, directly or indirectly, in, into or from the United States except pursuant to a registration statement that has been declared effective under the Securities Act or in transactions exempt from, or not subject to, the registration requirements of the Securities Act.

The offer and sale of Ordinary Shares referred to herein has not been and will not be under the applicable securities laws of Australia, Canada, Israel or Japan. Subject to certain exceptions, the Ordinary Shares referred to herein may not be offered or sold in Australia, Canada, Japan, Israel or to, or for the account or benefit of, any national, resident or citizen of Australia, Canada, Israel or Japan. There will be no public offer of the Ordinary Shares in the United States, Australia, Canada, Israel or Japan or elsewhere.

This announcement is only addressed to, and directed at, persons in member states of the European Economic Area other than the United Kingdom who are "qualified investors" within the meaning of Article 2(1)(e) of the Prospectus Directive ("Qualified Investors"). For the purposes of this provision, the expression "Prospectus Directive" means Directive 2003/71/EC, as amended, and includes any relevant implementing measure in each member state of the European Economic Area which has implemented the Prospectus Directive. In addition, in the United Kingdom, this announcement is being distributed only to, and is directed only at, qualified investors (i) who have professional experience in matters relating to investments who fall within the definition of "investment professional" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order"), or (ii) who are high net worth companies, unincorporated associations and partnerships and trustees of high value trusts as described in Article 49(2) of the Order, and (ii) other persons to whom it may otherwise lawfully be communicated (all such persons together being referred to as "relevant persons"). Any investment or investment activity to which this announcement relates is available only to and will only be engaged in with such persons. This announcement must not be acted on or relied on (i) in the United Kingdom, by persons who are not relevant persons, and (ii) in any member state of the European Economic Area other than the United Kingdom, by persons who are not qualified investors.

Canaccord Genuity Limited, which is authorised and regulated by the Financial Conduct Authority, and Leumi are acting exclusively for the Company and no-one else in connection with the Offer. They will not regard any other person as their respective clients in relation to the Offer and will not be responsible to anyone other than the Company for providing the protections afforded to their respective clients, nor for providing advice in relation to the Offer, the contents of this announcement or any transaction, arrangement or other matter referred to herein.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PDIQKCDDNBKDOOK
Date   Source Headline
3rd Aug 20178:25 amRNSMatomy Media Group- Update on Total Voting Rights
11th Jul 20177:00 amRNSTrading Update and Preliminary Interim Results
6th Jul 20177:00 amRNSMatomy Announces Sale of Its Non-Core Businesses
14th Jun 20177:00 amRNSMatomy- Senior Management Team Changes
5th Jun 20174:59 pmRNSMatomy- Update on Total Voting Rights
30th May 20177:00 amRNSMatomy- Notification of Major Interest in Shares
8th May 20178:44 amRNSMatomy Announces New Strategic Focus
4th May 20177:17 amRNSMatomy Media Group- Publication of Annual Report
13th Apr 20177:00 amRNSMatomy Media Group - Changing in Management
6th Apr 20175:22 pmRNSMatomy- Update on Total Voting Rights
24th Mar 20177:00 amRNSMatomy Media Group 2016 Final Results
21st Mar 20172:33 pmRNSMatomy - Notice of Results and Analyst Briefing
8th Mar 20172:38 pmRNSMatomy Media Group- Update on Total Voting Rights
3rd Feb 20171:21 pmRNSMMG- Block Listing & Update on Total Voting Rights
19th Jan 201712:01 pmRNSMatomy-Appointment of Chairman and Deputy Chairman
13th Jan 20177:21 amRNSPartial Option Exercise - Team Internet AG Shares
11th Jan 201710:28 amRNSMatomy Media Group - Result of EGM
22nd Dec 20164:54 pmRNSMMG- AMENDMENT TO FORMS OF PROXY AND INSTRUCTION
5th Dec 20169:09 amRNSNotice of AGM and Board Changes
8th Nov 20163:13 pmRNSTotal Voting Rights
4th Nov 20167:00 amRNSResult of EGM
2nd Nov 20165:10 pmRNSUpdate regarding EGM
18th Oct 20167:00 amRNSStrategic Review
7th Oct 20163:38 pmRNSMatomy Media Group - Update on Total Voting Rights
30th Sep 20164:42 pmRNSMatomy Media Group - Notice of EGM
21st Sep 20167:00 amRNSMatomy Media Group 2016 Interim Results
12th Sep 20164:41 pmRNSMatomy Shareholders Request Convention of EGM
8th Sep 20165:23 pmRNSMatomy- Notification of Major Interest in Shares
8th Sep 20167:00 amRNSMatomy Media Group - Update on Total Voting Rights
7th Sep 20169:14 amRNSMMG - Notice of Results and Analyst Briefing
5th Aug 20167:00 amRNSMatomy- Notification of Major Interest in Shares
5th Aug 20167:00 amRNSMatomy Media Group -Update on Total Voting Rights
6th Jul 20167:00 amRNSStrategic Investment Plan and Trading Update
9th Jun 201610:25 amRNSMatomy Media Group- Update on Total Voting Rights
11th May 20161:35 pmRNSMatomy- Notification of Major Interest in Shares
10th May 20163:34 pmRNSMatomy Media Group - Update on Total Voting Rights
5th May 20164:40 pmRNSSecond Price Monitoring Extn
5th May 20164:35 pmRNSPrice Monitoring Extension
3rd May 20167:00 amRNSMatomy Media Group- Publication of Annual Report
3rd May 20167:00 amRNSMatomy Media Group- Results of EGM
27th Apr 20164:30 pmRNSResignation of Director
1st Apr 20163:04 pmRNSMatomy - Notification of Transactions of Director
22nd Mar 201610:57 amRNSMatomy - Director Appointment and Notice of EGM
21st Mar 20167:00 amRNSMatomy Media Group 2015 Final Results
18th Mar 20164:41 pmRNSSecond Price Monitoring Extn
18th Mar 20164:35 pmRNSPrice Monitoring Extension
18th Mar 20167:00 amRNSMatomy Selected for Inclusion in TASE Indexes
16th Mar 20169:18 amRNSCorrection - Analyst Briefing
14th Mar 20168:20 amRNSNotice of Results and Analyst Briefing
10th Feb 20164:30 pmRNSMatomy Announces Commencement of Trading on TASE

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.